modimelanotide (ABT-719) - Zealand Pharma, AbbVie
Zealand Pharma: ADA 2013 (Zealand Pharma) - Jun 28, 2013 - Anticipated initiation of second Phase IIb study in acute kidney injury in 2013 
Anticipated new P2b trial • Renal Disease
http://www.zealandpharma.com/investors/events/event-archive
 
Jun 28, 2013
 
.